Sun X - Search Results

1

Efficacy and safety of immune checkpoint inhibitors plus recombinant human endostatin therapy as second-line treatment in advanced non-small-cell lung cancer with negative driver gene: a pilot study.

Yang B, Li Y, Deng J, Yang H, Sun X. Yang B, et al. Among authors: sun x. Front Oncol. 2023 Nov 7;13:1210267. doi: 10.3389/fonc.2023.1210267. eCollection 2023. Front Oncol. 2023. PMID: 38023216 Free PMC article.

2

Efficacy and mechanism of osimertinib combined with bevacizumab in the treatment of postoperative EGFR positive stage II-IIIA lung adenocarcinoma.

Bao J, Wu Z, Zhang C, Zhang M, Wang Y, Li H, Sun X, Gao J, Ge L, Li Y, Wang H, Guo Q. Bao J, et al. Among authors: sun x. Am J Transl Res. 2022 Jan 15;14(1):633-642. eCollection 2022. Am J Transl Res. 2022. PMID: 35173881 Free PMC article.

3

Survival analysis of patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi-center retrospective study.

Shi Q, Guan M, Wang Y, Xu C, Tang L, Fu W, Bi M, Sun X, Gu K, Pang D. Shi Q, et al. Among authors: sun x. Thorac Cancer. 2018 Feb;9(2):278-283. doi: 10.1111/1759-7714.12577. Epub 2017 Dec 20. Thorac Cancer. 2018. PMID: 29266865 Free PMC article.

4

Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling.

Sun X, Xu Y, Wang Y, Chen Q, Liu L, Bao Y. Sun X, et al. Med Sci Monit. 2018 May 15;24:3193-3203. doi: 10.12659/MSM.909977. Med Sci Monit. 2018. PMID: 29763936 Free PMC article.

5

Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.

Sun X, Zhang H, Luo L, Zhong K, Ma Y, Fan L, Fu D, Wan L. Sun X, et al. Oncol Rep. 2016 Dec;36(6):3131-3138. doi: 10.3892/or.2016.5159. Epub 2016 Oct 11. Oncol Rep. 2016. PMID: 27748938 Free PMC article.

6

Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.

Chen Y, You F, Jiang L, Li J, Zhu X, Bao Y, Sun X, Tang X, Meng H, An G, Zhang B, Yang L. Chen Y, et al. Among authors: sun x. Oncotarget. 2017 Jun 6;8(23):37128-37139. doi: 10.18632/oncotarget.16201. Oncotarget. 2017. PMID: 28415754 Free PMC article.

7

MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.

Sun X, Lou L, Zhong K, Wan L. Sun X, et al. Exp Biol Med (Maywood). 2017 Jun;242(12):1299-1305. doi: 10.1177/1535370217701625. Epub 2017 Apr 21. Exp Biol Med (Maywood). 2017. PMID: 28429654 Free PMC article.

8

Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner.

Yu T, Liu Y, Xue J, Sun X, Zhu D, Ma L, Guo Y, Jin T, Cao H, Chen Y, Zhu T, Li X, Liang H, Du Z, Shan H. Yu T, et al. Among authors: sun x. Cell Death Discov. 2022 Jul 9;8(1):312. doi: 10.1038/s41420-022-01104-3. Cell Death Discov. 2022. PMID: 35810157 Free PMC article.

9

Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.

Yu Y, Li J, Zhu X, Tang X, Bao Y, Sun X, Huang Y, Tian F, Liu X, Yang L. Yu Y, et al. Among authors: sun x. Int J Nanomedicine. 2017 Mar 13;12:1969-1983. doi: 10.2147/IJN.S127575. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28331319 Free PMC article.

10

[Correlation between Toxoplasma gondii infection and spontaneous abortion in pregnant women: a case-control study].

Sun XJ, Guo CJ, Shi H. Sun XJ, et al. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020 Aug 24;32(4):423-425. doi: 10.16250/j.32.1374.2020217. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020. PMID: 32935522 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,278 results

Search Page

Filters